Cape Town, South Africa (CU)_ The South African Health Regulatory Products Authority has granted permission to the US-listed business to begin their clinical studies and register patients in Phase 1 trials. The company claims that pills would be much less expensive compared to injections supplied by Moderna and Pfizer, and this will also eliminate the costs associated with the need for medical personnel to deliver them. Additionally, tablets have fewer side effects compared to injections.
Oramed Pharmaceuticals received clearance to conduct an initial clinical study in South Africa for its…
